A joint research group from KAIST and Institut Pasteur Korea
Antibiotic could be repurposed and added to tuberculosis treatment arsenal
Research has found fidaxomicin, an antibiotic usually used to treat
Commonly used anti-rejection drug could be repurposed to treat some liver cancers
Research from the University of Pittsburgh School of Medicine in